Related Experiment Video
Updated: Feb 26, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Frequency, Timing, and Impact of Access-Site and Non-Access-Site Bleeding on Mortality Among Patients Undergoing
Raffaele Piccolo1, Thomas Pilgrim1, Anna Franzone1
1Department of Cardiology, Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland.
Insights
Bleeding after transcatheter aortic valve replacement (TAVR) increases mortality risk. Non-access-site bleeding poses a significantly higher mortality risk than access-site bleeding in TAVR patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- Bleeding complications are common in patients undergoing transcatheter aortic valve replacement (TAVR).
- The prognostic impact of bleeding location (access-site vs. non-access-site) after TAVR remains unclear.
- Understanding bleeding site impact is crucial for improving TAVR patient outcomes.
Purpose of the Study:
- To investigate the frequency and timing of access-site and non-access-site bleeding post-TAVR.
- To assess the association of bleeding location with long-term mortality after TAVR.
- To compare the mortality risk conferred by access-site versus non-access-site bleeding.
Main Methods:
- Retrospective analysis of 926 consecutive patients undergoing TAVR (2007-2014).
- Bleeding events classified using Valve Academic Research Consortium 2 criteria.
- Primary outcome: All-cause mortality assessed up to 5 years post-procedure.
Main Results:
- 30.7% of patients experienced bleeding within 5 years.
- Both access-site (HR: 1.34) and non-access-site bleeding (HR: 2.08) significantly increased mortality risk.
- Non-access-site bleeding demonstrated a substantially higher mortality risk (HR: 1.56) compared to access-site bleeding.
Conclusions:
- Access-site and non-access-site bleeding are independent predictors of increased mortality after TAVR.
- Non-access-site bleeding is associated with the greatest mortality risk in the long-term follow-up.
- Factors like female sex, chronic kidney disease, and STS score correlate with specific bleeding types.
Objectives:
The aim of this study was to examine the frequency, timing, and association of access-site and non-access-site bleeding with mortality in the setting of transcatheter aortic valve replacement (TAVR) during long-term follow-up.
Background:
Bleeding is frequent and associated with impaired prognosis in patients undergoing TAVR. It is currently unknown whether the site of bleeding differentially influences the outcomes of TAVR patients.
Methods:
In total, 926 consecutive patients undergoing TAVR from 2007 through 2014 were evaluated. Bleeding was assessed according to the Valve Academic Research Consortium 2 criteria. The primary outcome of interest was all-cause mortality up to 5 years of follow-up.
Results:
A total of 285 patients (30.7%) experienced at least 1 (minor, major, or life-threatening) bleeding event up to 5 years. Compared with patients not experiencing bleeding, the adjusted risk for all-cause mortality was significantly increased among patients with access-site (hazard ratio: 1.34; 95% confidence interval: 1.01 to 1.76; p = 0.04) and non-access-site bleeding (hazard ratio: 2.08; 95% confidence interval: 1.60 to 2.71; p < 0.001). However, non-access-site bleeding conferred a significantly higher risk for mortality compared with access-site bleeding (hazard ratio: 1.56; 95% confidence interval: 1.12 to 2.18; p = 0.009). At multivariate analysis, female sex was a significant correlate of access-site bleeding, whereas chronic kidney disease and the Society of Thoracic Surgeons score were significantly associated with non-access-site bleeding.
Conclusions:
Among patients with severe aortic stenosis undergoing TAVR, access-site and non-access-site bleeding were independently associated with an increased risk for mortality, with the greatest risk related to non-access-site bleeding during long-term follow-up.
More Related Videos
Related Concept Videos
Aneurysm IV: Nursing Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

